About the Company
biolase, inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. biolase’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. biolase is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BIOL News
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call Transcript March 21, 2024 BIOLASE, Inc. beats earnings expectations. Reported EPS is $-1.76, ...
Why BIOLASE Shares Are Surging Friday
BIOLASE, Inc. shares rise 31% after better-than-expected FY23 EPS results, strong revenue growth expected in 2024 due to increased laser adoption.
Biolase’s Strong Q4 Performance and Positive 2024 Outlook Affirm Buy Rating
Biolase (BIOL) has received a new Buy rating, initiated by Maxim Group analyst, Anthony Vendetti. Anthony Vendetti’s rating is based on a ...
Biolase: Q4 Earnings Snapshot
Earnings Snapshot ...
BIOLASE, Inc.: Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024
LAKE FOREST, CA / / March 21, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, who previously announced its preliminary financial results for the ...
Q4 2023 BIOLASE Inc Earnings Call
Nick Sherwood; Analyst; Maxim Group LLC Ed Woo; Analyst; Ascendiant Capital Markets LLC ...
Biolase: Q4 Earnings Snapshot
LAKE FOREST, Calif. (AP) — LAKE FOREST, Calif. (AP) — Biolase Inc. (BIOL) on Thursday reported a loss of $5.3 million in its fourth quarter. The Lake Forest, California-based company said it ...
Loading the latest forecasts...